Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
987.61
Dollar change
-5.74
Percentage change
-0.58
%
IndexNDX, S&P 500 P/E28.42 EPS (ttm)34.75 Insider Own4.28% Shs Outstand107.60M Perf Week3.65%
Market Cap108.40B Forward P/E20.78 EPS next Y47.54 Insider Trans-1.69% Shs Float105.06M Perf Month3.33%
Income3.95B PEG3.86 EPS next Q10.04 Inst Own84.71% Short Float1.30% Perf Quarter23.75%
Sales13.12B P/S8.26 EPS this Y3.41% Inst Trans-0.34% Short Ratio2.39 Perf Half Y18.86%
Book/sh237.41 P/B4.16 EPS next Y4.98% ROA12.67% Short Interest1.37M Perf Year30.33%
Cash/sh98.80 P/C10.00 EPS next 5Y7.36% ROE16.26% 52W Range684.80 - 995.97 Perf YTD12.45%
Dividend Est.- P/FCF27.97 EPS past 5Y10.31% ROI13.79% 52W High-0.84% Beta0.12
Dividend TTM- Quick Ratio4.94 Sales past 5Y19.99% Gross Margin82.95% 52W Low44.22% ATR (14)17.52
Dividend Ex-Date- Current Ratio5.69 EPS Y/Y TTM-8.55% Oper. Margin32.64% RSI (14)68.37 Volatility1.93% 1.89%
Employees13450 Debt/Eq0.10 Sales Y/Y TTM7.76% Profit Margin30.14% Recom1.76 Target Price1027.06
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q-2.96% Payout0.00% Rel Volume0.85 Prev Close993.35
Sales Surprise4.25% EPS Surprise10.52% Sales Q/Q0.58% EarningsFeb 02 BMO Avg Volume574.30K Price987.61
SMA203.50% SMA506.97% SMA20020.21% Trades Volume485,877 Change-0.58%
Date Action Analyst Rating Change Price Target Change
Jan-12-24Upgrade RBC Capital Mkts Sector Perform → Outperform $884 → $1076
Nov-09-23Initiated Deutsche Bank Hold $800
Nov-03-23Upgrade Raymond James Mkt Perform → Outperform $950
Aug-21-23Upgrade Canaccord Genuity Hold → Buy $720 → $992
Aug-21-23Reiterated Oppenheimer Perform $950 → $1050
Jun-28-23Downgrade Canaccord Genuity Buy → Hold $953 → $720
Mar-27-23Upgrade SVB Securities Market Perform → Outperform $834 → $976
Mar-24-23Upgrade Jefferies Hold → Buy $675 → $925
Mar-23-23Upgrade Raymond James Underperform → Mkt Perform
Jan-30-23Upgrade Cowen Market Perform → Outperform $775 → $875
Feb-23-24 10:20AM
01:00AM
01:00AM
Feb-22-24 01:55PM
Feb-21-24 10:00AM
07:00AM Loading…
07:00AM
Feb-18-24 12:45AM
Feb-16-24 01:00AM
12:59AM
Feb-10-24 08:30AM
Feb-09-24 06:45AM
Feb-06-24 04:05PM
06:45AM
Feb-05-24 07:00AM
Feb-03-24 08:10AM
01:53AM Loading…
01:53AM
Feb-02-24 03:43PM
02:09PM
12:05PM
11:20AM
09:30AM
07:45AM
07:32AM
07:01AM
06:59AM
06:55AM
06:49AM
06:47AM
06:30AM
06:00AM
05:23PM Loading…
Feb-01-24 05:23PM
05:01PM
02:07AM
Jan-31-24 11:20AM
Jan-30-24 09:15AM
07:32AM
07:09AM
07:00AM
04:15AM
Jan-27-24 07:54AM
Jan-26-24 10:00AM
Jan-25-24 11:52PM
02:49PM
02:34PM
02:30PM
02:29PM
Jan-24-24 06:30PM
12:05PM
Jan-21-24 07:15AM
Jan-17-24 11:21AM
04:30AM
Jan-16-24 07:00AM
Jan-12-24 04:04PM
12:00PM
Jan-10-24 10:51AM
10:07AM
Jan-09-24 11:24AM
Jan-08-24 04:40PM
08:04AM
07:30AM
06:51AM
06:48AM
Jan-05-24 04:05PM
Jan-04-24 02:52PM
12:47PM
08:30AM
01:21AM
Jan-03-24 12:20PM
10:32AM
Dec-27-23 04:33PM
Dec-22-23 09:45AM
Dec-21-23 08:15PM
Dec-18-23 04:05PM
Dec-17-23 05:00AM
Dec-16-23 07:01AM
Dec-14-23 09:00AM
Dec-12-23 03:04PM
Dec-11-23 07:30AM
Dec-10-23 07:30PM
12:30PM
Dec-08-23 12:07PM
07:45AM
Dec-07-23 07:44PM
05:34PM
07:00AM
02:30AM
Dec-06-23 03:45PM
Dec-04-23 06:19AM
Dec-02-23 02:05PM
Nov-30-23 04:05PM
Nov-27-23 04:27PM
10:35AM
06:00AM
01:30AM
Nov-24-23 11:29AM
Nov-15-23 04:05PM
Nov-13-23 09:00AM
Nov-09-23 10:01PM
09:53AM
Nov-07-23 11:15PM
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SING GEORGE LDirectorFeb 26Option Exercise413.331,000413,33026,849Feb 28 04:04 PM
Bassler Bonnie LDirectorFeb 26Option Exercise391.92854334,7002,236Feb 26 04:07 PM
SING GEORGE LDirectorFeb 26Sale992.501,000992,50026,349Feb 28 04:04 PM
LAROSA JOSEPH JEVP General Counsel and SecretFeb 26Sale990.001,000990,00036,543Feb 28 04:04 PM
Bassler Bonnie LDirectorFeb 26Sale979.25854836,2801,382Feb 26 04:07 PM
SING GEORGE LDirectorFeb 23Option Exercise413.33500206,66526,849Feb 26 04:07 PM
SING GEORGE LDirectorFeb 23Sale985.00500492,50026,349Feb 26 04:07 PM
SING GEORGE LDirectorFeb 22Option Exercise413.333,0001,239,99027,349Feb 26 04:07 PM
SING GEORGE LDirectorFeb 22Sale965.003,0002,895,00026,349Feb 26 04:07 PM
LAROSA JOSEPH JEVP General Counsel and SecretFeb 22Sale967.651,000967,65037,543Feb 26 04:07 PM
YANCOPOULOS GEORGEBd. Co-Chair, President & CSOFeb 15Option Exercise399.66172,72369,030,474925,209Feb 20 04:03 PM
Van Plew Daniel PEVP & General Mgr, IndustrialFeb 14Sale942.2810,4349,831,72720,378Feb 16 04:15 PM
Van Plew Daniel PEVP & General Mgr, IndustrialFeb 09Option Exercise378.3035,37513,382,51047,153Feb 13 04:04 PM
SING GEORGE LDirectorFeb 09Option Exercise413.33500206,66526,849Feb 12 04:02 PM
Fenimore Christopher R.SVP Finance & CFOFeb 09Sale953.314,9194,689,32014,372Feb 12 04:02 PM
SING GEORGE LDirectorFeb 09Sale955.00500477,50026,349Feb 12 04:02 PM
SING GEORGE LDirectorFeb 08Option Exercise413.33500206,66526,849Feb 12 04:02 PM
SING GEORGE LDirectorFeb 08Sale945.00500472,50026,349Feb 12 04:02 PM
STAHL NEILEVP Research and DevelopmentFeb 07Sale950.358,0377,637,95452,019Feb 08 04:02 PM
LAROSA JOSEPH JEVP General Counsel and SecretFeb 07Sale950.001,000950,00038,543Feb 09 04:12 PM
McCourt MarionEVP CommercialFeb 05Sale934.711,000934,71013,789Feb 06 04:08 PM
STAHL NEILEVP Research and DevelopmentFeb 02Option Exercise399.6630,75012,289,54582,769Feb 06 04:08 PM
Landry Robert EEVP Finance CFOFeb 02Option Exercise378.98400151,59223,974Feb 06 04:08 PM
McCourt MarionEVP CommercialFeb 01Sale945.61273258,15214,789Feb 02 04:02 PM
RYAN ARTHUR FDirectorFeb 01Sale954.2210095,42218,382Feb 05 04:05 PM
Landry Robert EEVP Finance CFOJan 31Option Exercise378.98400151,59223,856Feb 02 04:02 PM
Bassler Bonnie LDirectorJan 30Option Exercise380.95827315,0462,209Jan 31 04:52 PM
Bassler Bonnie LDirectorJan 30Sale959.00827793,0931,382Jan 31 04:52 PM
Landry Robert EEVP Finance CFOJan 24Option Exercise378.98500189,49023,808Jan 25 04:17 PM
Fenimore Christopher R.SVP ControllerJan 23Option Exercise477.6710,0004,776,65022,874Jan 25 04:17 PM
GOLDSTEIN JOSEPH LDirectorJan 23Option Exercise625.602,7071,693,4999,089Jan 25 04:18 PM
Landry Robert EEVP Finance CFOJan 23Option Exercise378.981,100416,87824,084Jan 25 04:17 PM
GOLDSTEIN JOSEPH LDirectorJan 23Sale950.002,7072,571,6506,382Jan 25 04:18 PM
Landry Robert EEVP Finance CFOJan 17Option Exercise378.98500189,49023,338Jan 18 04:02 PM
Landry Robert EEVP Finance CFOJan 12Option Exercise378.98800303,18423,406Jan 17 04:03 PM
Landry Robert EEVP Finance CFOJan 04Option Exercise378.98500189,49022,948Jan 08 04:02 PM
LAROSA JOSEPH JEVP General Counsel and SecretJan 03Option Exercise399.6634,00013,588,44064,036Jan 04 04:19 PM
Fenimore Christopher R.SVP ControllerJan 03Option Exercise477.6710,0004,776,65020,329Jan 04 04:22 PM
Landry Robert EEVP Finance CFOJan 03Option Exercise378.981,100416,87823,136Jan 04 04:19 PM
Bassler Bonnie LDirectorJan 03Option Exercise380.95826314,6652,208Jan 04 04:11 PM
Bassler Bonnie LDirectorJan 03Sale914.00826754,9641,382Jan 04 04:11 PM
Zoghbi Huda YDirectorJan 02Option Exercise391.921,117437,7752,364Jan 04 04:11 PM
Landry Robert EEVP Finance CFOJan 02Option Exercise378.98650246,33722,457Jan 04 04:19 PM
YANCOPOULOS GEORGEBd. Co-Chair, President & CSOJan 02Sale900.0016,84815,163,200180,000Jan 04 04:20 PM
Zoghbi Huda YDirectorJan 02Sale900.001,1171,005,3001,247Jan 04 04:11 PM
McCourt MarionEVP CommercialJan 02Sale873.91274239,45115,062Jan 04 04:17 PM
RYAN ARTHUR FDirectorJan 02Sale899.9010089,99018,347Jan 04 04:08 PM
Landry Robert EEVP Finance CFODec 28Option Exercise378.98850322,13322,419Dec 29 04:05 PM
BROWN MICHAEL SDirectorDec 27Option Exercise482.682,049989,0113,296Dec 29 04:06 PM
Landry Robert EEVP Finance CFODec 27Option Exercise378.98750284,23522,111Dec 29 04:05 PM
Fenimore Christopher R.SVP ControllerDec 27Sale856.712,4482,097,22614,372Dec 29 04:04 PM
BROWN MICHAEL SDirectorDec 27Sale898.002,0491,840,0021,247Dec 29 04:06 PM
Fenimore Christopher R.SVP ControllerDec 22Sale846.27250211,56816,820Dec 26 04:08 PM
Fenimore Christopher R.SVP ControllerDec 21Sale844.011,6801,417,93417,070Dec 26 04:08 PM
Landry Robert EEVP Finance CFODec 13Option Exercise378.981,000378,98022,084Dec 14 04:08 PM
Bassler Bonnie LDirectorDec 13Option Exercise376.69610229,7811,857Dec 14 04:07 PM
Bassler Bonnie LDirectorDec 13Sale870.00610530,7001,247Dec 14 04:07 PM
McCourt MarionEVP CommercialDec 11Sale838.44270226,37920,814Dec 12 04:04 PM
MURPHY ANDREW JEVP ResearchDec 05Sale817.446,5365,342,78759,421Dec 06 04:02 PM
MURPHY ANDREW JEVP ResearchDec 04Option Exercise270.4320,0005,408,60079,421Dec 06 04:02 PM
RYAN ARTHUR FDirectorDec 01Sale817.3010081,73018,447Dec 04 04:02 PM
MURPHY ANDREW JEVP ResearchNov 14Sale799.176,4925,188,21359,421Nov 15 04:02 PM
MURPHY ANDREW JEVP ResearchNov 13Option Exercise270.4320,0005,408,60079,421Nov 15 04:02 PM
RYAN ARTHUR FDirectorNov 07Sale827.9010082,79018,547Nov 08 04:07 PM
McCourt MarionEVP CommercialNov 01Option Exercise381.401,000381,40020,803Nov 02 04:03 PM
McCourt MarionEVP CommercialNov 01Sale783.911,000783,91019,803Nov 02 04:03 PM
Zoghbi Huda YDirectorOct 13Option Exercise391.921,000391,9202,247Oct 17 04:06 PM
Zoghbi Huda YDirectorOct 13Sale850.001,000850,0001,247Oct 17 04:06 PM
McCourt MarionEVP CommercialOct 02Option Exercise372.461,038386,61320,841Oct 03 04:04 PM
McCourt MarionEVP CommercialOct 02Sale827.001,038858,42619,803Oct 03 04:04 PM
McCourt MarionEVP CommercialSep 01Sale834.55250208,63819,803Sep 06 04:03 PM
Van Plew Daniel PEVP & General Mgr, IndustrialAug 24Sale841.716,1975,216,07321,508Aug 25 04:02 PM
Van Plew Daniel PEVP & General Mgr, IndustrialAug 23Option Exercise381.4023,1258,819,87544,633Aug 25 04:02 PM
POON CHRISTINE ADirectorAug 23Option Exercise273.6712,2803,360,66814,317Aug 25 04:02 PM
Fenimore Christopher R.SVP ControllerAug 23Option Exercise399.667,0002,797,62026,140Aug 25 04:03 PM
POON CHRISTINE ADirectorAug 23Sale839.9712,28010,314,8292,037Aug 25 04:02 PM
Landry Robert EEVP Finance CFOAug 23Sale844.00223188,21231,699Aug 25 04:02 PM
STAHL NEILEVP Research and DevelopmentAug 22Sale840.9811,6659,810,08253,100Aug 23 04:03 PM
STAHL NEILEVP Research and DevelopmentAug 21Option Exercise399.6650,00019,983,000103,100Aug 23 04:03 PM
Bassler Bonnie LDirectorAug 21Option Exercise391.92853334,3082,100Aug 23 04:03 PM
Bassler Bonnie LDirectorAug 21Sale829.00853707,1371,247Aug 23 04:03 PM
Bassler Bonnie LDirectorAug 10Option Exercise391.92853334,3082,100Aug 11 04:13 PM
Bassler Bonnie LDirectorAug 10Sale789.00853673,0171,247Aug 11 04:13 PM
McCourt MarionEVP CommercialAug 01Sale744.66250186,16520,053Aug 03 04:02 PM
RYAN ARTHUR FDirectorAug 01Sale736.5910073,65918,647Aug 03 04:25 PM
McCourt MarionEVP CommercialJul 03Sale710.09250177,52220,303Jul 06 04:02 PM
RYAN ARTHUR FDirectorJul 03Sale716.8810071,68818,747Jul 06 04:01 PM
McCourt MarionEVP CommercialJun 01Sale736.00250184,00020,553Jun 02 04:12 PM
RYAN ARTHUR FDirectorJun 01Sale735.4210073,54218,847Jun 02 04:14 PM
RYAN ARTHUR FDirectorMay 01Sale805.3310080,53318,947May 03 04:01 PM
BROWN MICHAEL SDirectorApr 21Option Exercise520.013,0701,596,4314,317Apr 24 04:05 PM
BROWN MICHAEL SDirectorApr 21Sale798.423,0702,451,1491,247Apr 24 04:05 PM
McCourt MarionEVP CommercialApr 03Option Exercise372.461,100409,70621,903Apr 05 04:00 PM
McCourt MarionEVP CommercialApr 03Sale818.801,100900,68020,803Apr 05 04:00 PM
RYAN ARTHUR FDirectorApr 03Sale819.3110081,93119,047Apr 05 04:01 PM
Landry Robert EEVP Finance CFOMar 28Sale823.471,007829,23331,922Mar 29 04:07 PM
Landry Robert EEVP Finance CFOMar 27Option Exercise379.603,8001,442,47635,316Mar 29 04:07 PM
Landry Robert EEVP Finance CFOMar 27Sale821.70183150,37232,929Mar 29 04:07 PM
Bassler Bonnie LDirectorMar 24Option Exercise380.951,240472,3782,487Mar 27 04:43 PM
Bassler Bonnie LDirectorMar 24Sale818.001,2401,014,3201,247Mar 27 04:43 PM